DEVELOPING A HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY TECHNIQUE FOR THE DETERMINATION OF VORICONAZOLE PLASMA CONCENTRATION

Ngọc Diễm Dương, Tử Thiện Tâm Nguyễn, Thiên Dung Nguyễn, Thị Kim Yến Đỗ, Anh Duy Nguyễn, Thị Thúy Lan Trương, Thị Hồng Kim Trần, Thị Nguyệt Thu Nguyễn, Xuân Quang Lý, Thị Hải Hà Văn, Nguyễn Đoan Trang Đặng

Main Article Content

Abstract

Aims. To develop a novel high-performance liquid chromatography (HPLC) technique to determine VRC concentration in human plasma.Methods. The peak of voriconazole (VRC) was detected using an XDB RP C18 (150x4,6mm, 5µm) column, a mobile phase of water: acetonitrile (60:40 v/v), at a flow rate of 1 mL/min. We also report a case of a 66-year-old male to demonstrate the application of this technique in clinical practices at the University Medical Center Ho Chi Minh City. Results. The HPLC method showed good accuracy, specificity, selectivity, and stability. A linear response (R2 = 0,9997) was observed in the range of 0,25–10µg/mL. There was a strong correlation between VRC concentration and clinical efficacy as well as toxicity. Conclusions. The novel technique allowed rapid detection of VRC in human plasma with a lower limit of quantification of 0.25 µg/mL. We have successfully applied this technique in clinical practices to maximize efficacy and minimize toxicity.

Article Details

References

1. Cendejas-Bueno E, Cuenca-Estrella M, Gomez-Lopez A (2013). Determination of voriconazole serum concentration by bioassay, a valid method for therapeutic drug monitoring for clinical laboratories. Antimicrobial Agents and Chemotherapy, 57(7):3437-3440.
2. ICH Expert Working Group (2022). Bioanalytical method validation and study sample analysis M10. ICH Harmonised Guideline: Geneva, Switzerland.
3. Kaza M, Karaźniewicz-Łada M, Kosicka K, et al (2019). Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse?. Journal of Pharmaceutical and Biomedical Analysis, 165:381-385.
4. McCreary EK, Davis MR, Narayanan N, et al (2023). Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists: Endorsed by the Mycoses Study Group Education and Research Consortium. Pharmacotherapy, 43(10):1043-1050.
5. Takesue Y, Hanai Y, Oda K, et al (2022). Clinical Practice Guideline for the Therapeutic Drug Monitoring of Voriconazole in Non-Asian and Asian Adult Patients: Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. Clinical Therapeutics, 44(12):1604-1623.
6. Tang PT (2013). Quantification of antifungal drug voriconazole in serum and plasma by HPLC-UV. Journal of Drug Metabolism and Toxicology, 4(144), 2.
7. Ullmann AJ, Aguado JM, Arikan-Akdagli S, et al (2018). Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. Clinical microbiology and infection, 24 Suppl 1:e1-e38.
8. Zufía L, Aldaz A, Ibáñez N, et al. (2023). Validation of an LC method for therapeutic drug monitoring of voriconazole in patients. Journal of Bioanalysis & Biomedicine, 2:035-043.